The authors report a case of in-stent restenosis (ISR) of the middle cerebral artery (MCA) following bare-metal stent (BMS) deployment and subsequent treatment using a drug-eluting stent (DES). This 65-year-old woman presented with frequent transient ischemic attacks. Initial studies revealed occlusion of the left internal carotid artery and severe stenosis of the right MCA with decreased cerebral perfusion in the bilateral MCA territories. Stent-assisted angioplasty of the right MCA was performed using a BMS, and satisfactory results were obtained with no complications. Six months after the procedure the patient presented with recurrent symptoms, and workups revealed ISR with decreased cerebral perfusion. A DES was successfully placed without complications. Follow-up studies at 3 and 8 months after retreatment showed sustained luminal integrity and cerebral perfusion. A combination of CT angiography and perfusion CT exhibited the anatomical results and hemodynamic status of the stenotic lesion, and these findings coincided with the patient's clinical symptoms and the results of conventional cerebral angiography.
In-stent restenosis of the MCA after placement of a BMS can be treated using a DES. A combination of CT angiography and perfusion CT can be an alternative to conventional angiography. Low-profile devices with an amelioration of trackability are essential for the further incorporation of the DES into the field of endovascular neurosurgery. More clinical experiences and long-term follow-ups are mandatory to evaluate the safety, efficacy, and durability of the DES.
Abbreviations used in this paper: BMS = bare-metal stent; DES = drug-eluting stent; EC-IC bypass = extracranial-intracranial bypass surgery; ICA = internal carotid artery; IAS = intracranial atherosclerotic stenosis; ISR = in-stent restenosis; MCA = middle cerebral artery.
Address correspondence to: Seong-Rim Kim, M.D., Department of Neurosurgery, Holy Family Hospital, The Catholic University of Korea, Sosa-dong 2, Wonmi-gu, Bucheon, Kyeonggi-do, 420-717, Republic of Korea. email:
Please include this information when citing this paper: published online September 11, 2009; DOI: 10.3171/2009.8.JNS081609.
AiroldiFRogackaRBriguoriCChieffoACarlinoMMontorfanoM: Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis. Am J Cardiol94:1297–13002004
EllisSGColomboAGrubeEPopmaJKoglinJDawkinsKD: Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol49:1043–10512007
FiorellaDChowMMAndersonMWooHRasmussenPAMasarykTJ: A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery61:236–2422007
GrinesCLBonowROCaseyDEJrGardnerTJLockhartPBMoliternoDJ: Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol49:734–7392007
HolmesDRJrTeirsteinPSatlerLSketchMO'MalleyJPopmaJJ: Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA295:1264–12732006
JinnouchiJToyodaKInoueTFujimotoSGotohSYasumoriK: Changes in brain volume 2 years after extracranial-intracranial bypass surgery: a preliminary subanalysis of the Japanese EC-IC trial. Cerebrovasc Dis22:177–1822006
PfistererMBrunner-La RoccaHPBuserPTRickenbacherPHunzikerPMuellerC: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus baremetal stents. J Am Coll Cardiol48:2584–25912006
TurkASRowleyHANiemannDBFiorellaDAagaard-KienitzBPulferK: CT angiographic appearance of in-stent restenosis of intracranial arteries treated with the Wingspan stent. AJNR Am J Neuroradiol28:1752–17542007
WeiszGLeonMBHolmesDRJrKereiakesDJClarkMRCohenBM: Two-year outcomes after sirolimus-eluting stent implantation. Results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial. J Am Coll Cardiol47:1350–13552006